- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07574151
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease Surveillance (ACCESS-TAD)
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease Surveillance: A Qualitative Feasibility Study.
People who are invited to take part in health research are usually given written information, such as invitation letters, and information sheets. These documents are essential because they help people understand what the study involves and decide whether they want to take part. However, many studies have shown that research information is often too complex, too long, or written in technical language. This can make it difficult for people to fully understand the study and give informed consent.
This study aims to assess how clear, accessible, and acceptable draft research documents are for a proposed future doctoral study related to thoracic aortic disease. Thoracic aortic disease is a long-term condition that requires regular monitoring, and people in surveillance programmes may be invited to take part in research. It is therefore important that study information is clear, sensitive, and easy to understand.
In this study, staff and students from the University's School of Health Sciences will be asked to review draft recruitment materials. These materials include a study invitation, an information sheet, and interview guide. Participants will be asked to give feedback on how easy the documents are to read, whether the information is clear, whether the tone feels appropriate, and whether the amount of information feels reasonable.
The study will also use a standard readability tool to assess whether the documents are written at a level suitable for the public.
This research does not involve patients and is considered low risk. Its purpose is to improve research materials before they are used with patients, helping to support informed consent, reduce confusion, and improve ethical and inclusive research practice in future studies.
연구 개요
상세 설명
BACKGROUND AND RATIONALE:
Recruitment materials such as information sheets, consent forms, and questionnaires help people decide whether they want to take part in research. These documents are important because they explain what the study involves and help people make an informed choice. If the information is too technical, too long, or given at the wrong time, people may feel confused, anxious, or decide not to take part.
People with thoracic aortic disease (TAD) attend regular hospital appointments for monitoring and imaging. During these visits, they may be invited to take part in research studies. These moments can be stressful, and patients may find it difficult to process complex research information.
This study will explore how recruitment materials are written, when they are given to patients, and how patients understand them in the context of thoracic aortic disease surveillance. The aim is to identify ways to make research information clearer, more appropriate, and easier to understand, so that people can make informed decisions about participation.
The findings will be used to improve recruitment materials and strategies for a future doctoral research study. This will help support ethical recruitment, reduce participant burden, and promote fair and inclusive participation in thoracic aortic disease research.
The study seeks to answer the following research questions:
- Are the recruitment research materials (including the study invitation, participant information sheet, and interview topic guide) clear and understandable?
- Are the materials written at an appropriate reading level for the public?
- How do potential participants perceive the tone, emotional impact, and acceptability of the materials?
- Do the materials clearly explain what participation would involve, including time commitment and expectations?
- What improvements can be made to enhance clarity, accessibility, and acceptability prior to use in future research?
STUDY AIMS
Main Aim To assess the clarity, accessibility, and acceptability of proposed Recruitment research materials developed for future doctoral study.
Objectives
- To evaluate whether Recruitment materials are clear and understandable.
- To assess the readability of materials using recognised readability tools.
- To explore perceptions of emotional tone and information burden.
- To examine the acceptability of proposed research procedures and participant burden
- To refine materials in preparation for further doctoral research.
STUDY DESIGN
Methodology:
This study uses a qualitative feasibility design to explore whether and how recruitment materials could be improved before using in a future doctoral research project. Qualitative methods are appropriate to examine perceptions of clarity, tone, accessibility, and perceived burden, which cannot be fully captured using quantitative measures. The study aims to generate practical insights rather than statistically generalisable findings, consistent with feasibility research principles.
Sampling Strategy:
Departmental mailing lists and internal communication will be used in a convenience sampling strategy. Recruitment materials will be widely distributed throughout the School of Health Sciences, and participation will be completely voluntary to reduce selection bias.
Methods of Data Collection:
Written feedback will be collected via an electronic form containing free text response questions. If responses lack sufficient depth, a small number of follow-up interviews or one focus group may be conducted to clarify key issues, minimising participant burden.
The form will be hosted on Microsoft Forms within the University of Nottingham secure Microsoft 365 platform, with access restricted to the research team. If written responses lack sufficient depth, a small purposive sample (2-6 participants) may be invited to follow-up interviews or one focus group.
Study Sequence and Duration:
The data collection tool is designed to balance depth of feedback with minimising participant burden; the estimated completion time is 15-20 minutes. If written responses do not provide sufficient depth to inform revisions, a small subset of participants will be invited to take part in follow up semi structured interviews (approximately 2-6 interviews) or one focus group will be convened to explore specific issues in more detail.
Number of participants & group allocations:
The research aims to recruit approximately 20-30 participants from the School of Health Sciences in accordance with feasibility research standards. This sample size is adequate for identifying recurring issues relating to clarity, accessibility, and acceptance while keeping data volume manageable for thematic analysis.
Methods of Data Analysis:
Qualitative data will be analysed using Braun and Clarke's (2006) reflexive thematic analysis. An inductive approach will allow unanticipated themes to emerge, appropriate for the study's exploratory aims. Analysis will involve familiarisation, initial coding (focusing on clarity, accessibility, tone, and burden), theme development, review, and refinement, followed by defining and naming final themes. Reflexive notes will document analytic decisions throughout. Readability scores will be integrated with qualitative interpretations by examining sections identified as challenging alongside participant feedback. This combined approach supports triangulation and enhances the credibility and depth of findings.
Recruitment Internal communication channels will be used to recruit participants from the University of Nottingham's School of Health Sciences.
Information provided to participants:
A study invitation explaining the purpose of the research, what participation involves, that participation is voluntary, and the anticipated time commitment will be included in the recruitment materials.
The invitation will be sent out through departmental mailing lists and, if applicable, staff communication platforms or internal virtual learning environments. The recruitment message will make it clear that participation is completely voluntary.
A Participant Information Sheet (PIS) will be sent to prospective participants who indicate interest. The aims, ethical approvals, research activities involved in the study and the researcher's and supervisor's contact information will all be provided in this document. The feedback form will only be accessible to those who have given their informed consent. This recruitment strategy reduces the possibility of perceived pressure, especially in situations where staff-student power relations may present and is consistent with ethical guidelines for low-risk university-based research.
Informed Consent:
Informed consent will be obtained prior to any data collection and will be completed electronically.
Participants will be given adequate time to read the PIS before deciding whether to take part. Contact details for the researcher and supervisor will be provided so that participants can ask questions or request clarification before consenting.
Consent will be recorded using a single online consent form. This form will include consent for:
- participation in the written feedback component, and
- being contacted for an optional follow-up interview or focus group, should further clarification be required.
Participants must actively confirm each consent statement (e.g. by ticking mandatory boxes) before proceeding. Data collection will not be possible unless consent has been provided.
Participation in any follow-up interview or focus group remains voluntary. Participants will be required to confirm consent before being interviewed or before taking part in an interview or focus group (as applicable).
Participant confidentiality:
The study staff will safeguard the privacy of participants' personal data. The study will comply with the General Data Protection regulation (GDPR) Data Protection Act 2018, which requires all personal data to be anonymised as soon as it is practical to do so. The processing of the personal data will be minimised by making use of a unique study ID number only on all study documents and any electronic database(s). Documents (such as consent forms) that contain identifying data and/or information allowing this to be linked to the participant ID will be stored separately under strict access controls. All documents will be stored securely and only accessible by study staff and authorised personnel. If participants agree for their contact details to be kept for the purpose of inviting them to take part in future research studies, their name, contact details will be stored on a separate database under strict access controls.
Discontinuation/ withdrawal of participants from study:
Participants may withdraw from the study at any time without giving a reason and without consequence. They may choose to:
- Withdraw from further involvement but allow data collected up to that point to be retained; or
- Withdraw and request deletion of their identifiable data, provided this occurs before anonymisation.
Once data has been anonymised, it will no longer be possible to remove an individual's contribution. This includes transcripts of audio recordings and focus group data, where individual comments cannot be separated without compromising the dataset. These limits will be explained in the PIS.
Definition of end of study The end of participant involvement in the study is the date of submission of feedback and if needed the date of an interview or focus group session.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Charles B Mensah, MA Research Methods- Health
- 전화번호: +44
- 이메일: ntxcm25@nottingham.ac.uk
연구 연락처 백업
- 이름: Mr Mensah
- 이메일: charlesbennettmensah3@gmail.com
연구 장소
-
-
-
Nottingham, 영국
- 모병
- School of Health Sciences ( University of Nottingham)
-
부수사관:
- Charles B Mensah, Mr
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Individuals who are staff or students within the School of Health Sciences at the University of Nottingham.
- Participants aged 18 years or older who can read and understand English.
Exclusion Criteria:
- Individuals who are unable to provide informed consent.
- Individuals who are unable to read or understand English
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Staff
Staff in the School of Health Sciences (University of Nottingham)
|
All study participants are assessing the clarity and acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease Surveillance
|
|
Student
Students in the School of Health Sciences (University of Nottingham)
|
All study participants are assessing the clarity and acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease Surveillance
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Clarity of recruitment materials
기간: up to 24 weeks
|
How well participants understand information provided
|
up to 24 weeks
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Charles B Mensah, MA Research Methods -Health, University of Nottingham
- 수석 연구원: Lesley Halliday, Dr, University of Nottingham
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- FMHS 131-0226
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
흉부 대동맥 질환에 대한 임상 시험
-
L2 Bio, LLCFDAMap; Akan Biosciences, Inc.아직 모집하지 않음Crohn & amp;#39; s | Crohn & amp;#39; s Disease (CD)
-
Vanderbilt University Medical CenterTakeda Pharmaceuticals U.S.A., Inc.모집하지 않고 적극적으로염증성 장질환(IBD) | 궤양성 대장염(UC) | Crohn & amp;#39; s Disease (CD)미국
-
Kaohsiung Medical University아직 모집하지 않음폐 선암종 | 폐암(진단) | Condition/Disease
-
Nandakumar NarayananNational Institute of Neurological Disorders and Stroke (NINDS)초대로 등록
-
Novartis Pharmaceuticals모병류마티스 관절염 (RA) 및 Sjögren 's Disease (SJD)스페인, 프랑스, 독일, 싱가포르
-
UNC Lineberger Comprehensive Cancer CenterFogarty International Center of the National Institute of Health모집하지 않고 적극적으로
-
University of PennsylvaniaEUSA Pharma, Inc.; Castleman Disease Collaborative Network모병캐슬맨병 | 캐슬맨병 | 거대 림프절 과형성 | 혈관여포 림프 증식증 | 혈관여포 림프절 과형성 | 혈관여포성 림프종 과형성 | GLNH | 과형성, 거대 림프절 | 림프절 과형성, 거인미국
Acceptability and Clarity에 대한 임상 시험
-
Radicle Science아직 모집하지 않음
-
Integra LifeSciences Corporation완전한
-
Radicle ScienceJeff Bland; Austin Perlmutter완전한
-
University of OregonSpecial X Inc.완전한부모-자녀 관계 | 육아 | 아동 행동 | 발달 장애 | 개발 지연 | 발달 장애, 아동미국
-
University Hospitals Cleveland Medical Center알려지지 않은
-
National University of Singapore완전한
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Angiogenesis Analytics아직 모집하지 않음